• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺瘤性息肉患者家族中的结直肠癌风险。国家息肉研究工作组。

Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup.

作者信息

Winawer S J, Zauber A G, Gerdes H, O'Brien M J, Gottlieb L S, Sternberg S S, Bond J H, Waye J D, Schapiro M, Panish J F

机构信息

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

N Engl J Med. 1996 Jan 11;334(2):82-7. doi: 10.1056/NEJM199601113340204.

DOI:10.1056/NEJM199601113340204
PMID:8531963
Abstract

BACKGROUND

The adenoma-adenocarcinoma sequence in colorectal cancer suggests an increased risk of colorectal cancer in the families of patients with adenomatous polyps.

METHODS

A random sample of participants in the National Polyp Study who had newly diagnosed adenomatous polyps were interviewed for information on the history of colorectal cancer in their parents and siblings. The risk of colorectal cancer in family members was analyzed according to the characteristics of the patients with adenomas and in comparison with a sample of patients' spouses, who served as controls.

RESULTS

Among the patients with adenomas, 1199 provided information on whether they had a family history of colorectal cancer. After the exclusion of families for which information was incomplete and of 48 patients who had been referred for colonoscopy solely because they had a family history of colorectal cancer, there were 1031 patients with adenomas, 1865 parents, 2381 siblings, and 1411 spouse controls. The relative risk of colorectal cancer, adjusted for the year of birth and sex, was 1.78 for the parents and siblings of the patients with adenomas as compared with the spouse controls (95 percent confidence interval, 1.18 to 2.67). The relative risk for siblings of patients in whom adenomas were diagnosed before 60 years of age was 2.59 (95 percent confidence interval, 1.46 to 4.58) as compared with the siblings of patients who were 60 or older at the time of diagnosis and after adjustment for the sibling's year of birth and sex and a parental history of colorectal cancer. The risk increased with decreasing age at the time of the diagnosis of adenoma (P for trend < 0.001). The relative risk for the siblings of patients who had a parent with colorectal cancer, as compared with those who had no parent with cancer, was 3.25 (95 percent confidence interval, 1.92 to 5.52), after adjustment for the sibling's year of birth and sex and the patient's age at diagnosis.

CONCLUSIONS

Siblings and parents of patients with adenomatous polyps are at increased risk for colorectal cancer, particularly when the adenoma is diagnosed before the age of 60 or--in the case of siblings--when a parent has had colorectal cancer.

摘要

背景

结直肠癌的腺瘤-腺癌序列提示腺瘤性息肉患者的家族成员患结直肠癌的风险增加。

方法

对国家息肉研究中随机抽取的新诊断为腺瘤性息肉的参与者进行访谈,了解其父母和兄弟姐妹的结直肠癌病史。根据腺瘤患者的特征分析家庭成员患结直肠癌的风险,并与作为对照的患者配偶样本进行比较。

结果

在腺瘤患者中,1199人提供了他们是否有结直肠癌家族史的信息。在排除信息不完整的家庭以及仅因有结直肠癌家族史而被转诊进行结肠镜检查的48名患者后,有1031名腺瘤患者、1865名父母、2381名兄弟姐妹和1411名配偶对照。在调整出生年份和性别后,腺瘤患者的父母和兄弟姐妹患结直肠癌的相对风险为1.78,而配偶对照为1.18至2.67(95%置信区间)。与诊断时年龄在60岁及以上的患者的兄弟姐妹相比,在调整兄弟姐妹的出生年份、性别和结直肠癌家族史后,腺瘤在60岁之前被诊断出的患者的兄弟姐妹的相对风险为2.59(95%置信区间,1.46至4.58)。风险随着腺瘤诊断时年龄的降低而增加(趋势P<0.001)。在调整兄弟姐妹的出生年份、性别和患者诊断时的年龄后,有结直肠癌父母的患者的兄弟姐妹与没有患癌父母的患者的兄弟姐妹相比,相对风险为3.25(95%置信区间,1.92至5.52)。

结论

腺瘤性息肉患者的兄弟姐妹和父母患结直肠癌的风险增加,特别是当腺瘤在60岁之前被诊断出时,或者在兄弟姐妹的情况下,当父母患有结直肠癌时。

相似文献

1
Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup.腺瘤性息肉患者家族中的结直肠癌风险。国家息肉研究工作组。
N Engl J Med. 1996 Jan 11;334(2):82-7. doi: 10.1056/NEJM199601113340204.
2
Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.新诊断增生性息肉患者随访评估中结直肠腺瘤发病率增加。
Surg Endosc. 2001 Jul;15(7):646-8. doi: 10.1007/s004640000389. Epub 2001 May 14.
3
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.结肠镜息肉切除术预防结直肠癌。国家息肉研究工作组。
N Engl J Med. 1993 Dec 30;329(27):1977-81. doi: 10.1056/NEJM199312303292701.
4
Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.PTGS1(=环氧化酶-1)基因多态性与结直肠息肉风险
Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):889-93.
5
First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer.晚期结直肠腺瘤患者的一级亲属患结直肠癌的几率更高。
Clin Gastroenterol Hepatol. 2003 Mar;1(2):96-102. doi: 10.1053/cgh.2003.50018.
6
Risk factors for colorectal adenomas among immediate family members of patients with colorectal cancer in Taiwan: a case-control study.台湾地区结直肠癌患者直系亲属中结直肠腺瘤的危险因素:一项病例对照研究。
Am J Gastroenterol. 2000 Dec;95(12):3624-8. doi: 10.1111/j.1572-0241.2000.03380.x.
7
Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.结直肠腺瘤性息肉和增生性息肉:吸烟与N-乙酰转移酶2基因多态性
Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):69-75.
8
High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up.在临床试验之外,息肉切除术后随访结肠镜检查也可实现高依从率:随访低依从性不会降低息肉切除术的疗效。
Colorectal Dis. 2004 May;6(3):158-61. doi: 10.1111/j.1463-1318.2004.00585.x.
9
Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.结肠镜切除新诊断腺瘤性息肉后监测间隔的随机对照比较。国家息肉研究工作组。
N Engl J Med. 1993 Apr 1;328(13):901-6. doi: 10.1056/NEJM199304013281301.
10
Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?增生性息肉和腺瘤性息肉的危险因素:恶性潜能的证据?
Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1012-8.

引用本文的文献

1
DDS Profile: Sidney J. Winawer.牙医博士简介:西德尼·J·维纳韦尔。
Dig Dis Sci. 2025 Apr 10. doi: 10.1007/s10620-025-09009-8.
2
Progress and Perspectives in Colon Cancer Pathology, Diagnosis, and Treatments.结肠癌病理学、诊断与治疗的进展及展望
Diseases. 2023 Oct 24;11(4):148. doi: 10.3390/diseases11040148.
3
AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review.AGA 临床实践更新:结直肠癌筛查和息肉切除术后监测的风险分层:专家综述。
Gastroenterology. 2023 Nov;165(5):1280-1291. doi: 10.1053/j.gastro.2023.06.033. Epub 2023 Sep 21.
4
Phenome-wide association study (PheWAS) of colorectal cancer risk SNP effects on health outcomes in UK Biobank.全表型关联研究(PheWAS)分析结直肠癌风险 SNP 对英国生物银行健康结局的影响。
Br J Cancer. 2022 Mar;126(5):822-830. doi: 10.1038/s41416-021-01655-9. Epub 2021 Dec 15.
5
Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals.高危个体中结直肠癌替代筛查策略的成本效益分析。
Therap Adv Gastroenterol. 2021 Apr 10;14:17562848211002359. doi: 10.1177/17562848211002359. eCollection 2021.
6
Risk of colorectal cancer in first degree relatives of patients with colorectal polyps: nationwide case-control study in Sweden.结直肠息肉患者一级亲属的结直肠癌风险:瑞典全国病例对照研究。
BMJ. 2021 May 4;373:n877. doi: 10.1136/bmj.n877.
7
The National Polyp Study at 40: challenges then and now.《国家息肉研究40年:当时与现在的挑战》
Gastrointest Endosc. 2021 Mar;93(3):720-726. doi: 10.1016/j.gie.2020.09.044. Epub 2020 Sep 30.
8
Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden.高级结直肠息肉与结直肠癌风险增加相关:筛查一级亲属和降低癌症负担的未开发机会。
Am J Gastroenterol. 2020 Jul;115(7):980-988. doi: 10.14309/ajg.0000000000000639.
9
Reinforced education improves the quality of bowel preparation for colonoscopy: An updated meta-analysis of randomized controlled trials.强化教育提高结肠镜检查肠道准备质量:一项更新的随机对照试验荟萃分析。
PLoS One. 2020 Apr 28;15(4):e0231888. doi: 10.1371/journal.pone.0231888. eCollection 2020.
10
Autocatalytic Tissue Polymerization Reaction Mechanism in Colorectal Cancer Development and Growth.结直肠癌发生和生长中的自催化组织聚合反应机制
Cancers (Basel). 2020 Feb 17;12(2):460. doi: 10.3390/cancers12020460.